FGFR3 and lip and oral cavity carcinoma: Sequencing data show that three patients bore a pathogenic amplification of either FGFR3 or CCDN1. Indeed, amplification of FGFR3 and CCDN1 have been independently reported to be associated to oral carcinoma and both represent a biomarker of poor prognosis (33–36).